The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 1, 2000, Pages 70-79

  Bocan, Thomas M A ^a   Krause, Brian R ^a   Rosebury, Wendy S ^a   Bak Mueller, Sandra ^a   Lu, Xiaokang ^a   Dagle, Catherine ^a   Major, Terry ^a   Lathia, Chetan ^a   Lee, Helen ^a  

^a PFIZER INC   (United States)

Author keywords

ACAT; Atherosclerosis; Macrophages; Matrix metalloproteinases; Plaque rupture

Indexed keywords

AVASIMIBE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; FAT INTAKE; HYPERCHOLESTEROLEMIA; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TREATMENT OUTCOME;

EID: 0033972030     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.1.70     Document Type: Article

References (34)

1. Small D. Progression and regression of atherosclerotic lesions: insights from lipid physical biochemistry. Arteriosclerosis. 1988;8:103-129.
2. Smith EB, Evans PH, Downham MD. Lipid in the aortic intima: the correlation of morphological and chemical characteristics. J Atheroscler Res. 1967;7:171-186.
3. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223-261.
4. Haust MD. The natural history of human atherosclerotic lesions. In: Moore S, ed. Vascular Injury and Atherosclerosis. New York, NY: Marcel Dekker; 1981:1-23.
5. Galis ZS, Sukhova GK, Kranzhoefer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A. 1995;92:402-406.
6. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
7. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, Clowes AW. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995;92:1398-1408.
8. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A. 1996;93: 9748-9753.
9. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation. 1995;91:2125-2131.
10. Krause BR, Bocan TMA. ACAT inhibitors: physiologic mechanisms for hypolipidemic and anti-atherosclerotic activities in experimental animals. In: Ruffolo RR, Hollinger MA, eds. Inflammation: Mediators and Pathways. Boca Raton, Fla: CRC Press; 1995:173-198.
11. Krause BR, Sliskovic DR, Bocan TMA. Emerging therapies in atherosclerosis. Exp Opin Invest Drugs. 1995;4:353-387.
12. Roth BD. ACAT inhibitors: evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents. Drug Discovery Today. 1998; 3:19-25.
13. Bocan TMA. Animal models of atherosclerosis and interpretation of drug intervention studies. Curr Pharm Des. 1998;4:39-53.
14. Bocan TMA, Bak Mueller S, Uhlendorf PD, Newton RS, Krause BR. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions: a biochemical, morphological and morphometric evaluation. Arterioscler Thromb. 1991;11:1830-1843.
15. Constantinides P, Booth J, Carlson G. Production of advanced cholesterol atherosclerosis in the rabbit. Arch Pathol. 1960;70:80-92.
16. Constantinides P. Production of experimental atherosclerosis in animals. J Atheroscler Res. 1961;1:374-385.
17. Lee HT, Sliskovic DR, Picard JA, Roth BD, Wierenga W, Hicks JL, Bousley RF, Hamelehle KL, Homan R, Speyer C, Stanfield RL, Krause BR. Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents: CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets. J Med Chem. 1996;39:5031-5034.
18. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20: 470-475.
19. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476-482.
20. Bocan TMA, Bak Mueller S, Uhlendorf PD, Ferguson E, Newton RS. Dietary and mechanically induced rabbit iliac-femoral atherosclerotic lesions. Exp Mol Pathol. 1991;54:210-217.
21. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem. 1957;226:497-509.
22. Snell JC, Chernyshev O, Gilbert DL, Colton CA. Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages. J Leukoc Biol. 1997;62:369-373.
23. Homan R, Anderson MK. Rapid separation and quantitation of combined neutral and polar lipid classes by high-performance liquid chromatography and evaporative light-scattering mass detection. J Chromatogr B. 1998;708:21-26.
24. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
26. Thompson SW. Selected Histochemical and Histopathological Methods. Springfield, Mass: Charles C Thomas Publishing; 1966: 1-1639.
27. Tsukada T, Rosenfeld M, Ross R, Gown AM. Immunocytochemical analysis of cellular components in atherosclerotic lesions: use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis. 1986;6:601-613.
28. Gown AM, Vogel AM, Gordon D, Lu PL. A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol. 1985;100:807-813.
29. Bocan TMA, Mazur MJ, Bak Mueller S, Quenby-Brown E, Sliskovic DR, O'Brien P, Creswell MW, Lee H, Uhlendorf PD, Roth BD, Newton RS. Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation. Atherosclerosis. 1994; 111:127-142.
30. Shanks ME, Gambill R. Calculus Analytic Geometry/Elementary Functions. New York, NY: Holt Rinehart & Winston: 1973:1-748.
31. Ott L. An Introduction to Statistical Methods and Data Analysis. North Scituate, Mass: Duxbury Press; 1977:1-730.
32. Daugherty A, Schonfeld G, Sobel BE, Lange LG. Metabolism of very low density lipoproteins after cessation of cholesterol feeding in rabbits. J Clin Invest. 1986;77:1108-1115.
33. Ho KJ, Pang LC, Taylor CB. Mode of cholesterol accumulation in various tissues of rabbits with prolonged exposure to various serum cholesterol levels. Atherosclerosis. 1974;19:561-566.
34. Kellner-Weibel G, Jerome WG, Small DM, Warner GJ, Stoltenborg JK, Kearney MA, Corjay MH, Phillips MC, Rothblat GH. Effects of intra-cellular free cholesterol accumulation on macrophage viability: a model of foam cell death. Arterioscler Thromb Vasc Biol. 1998;18:423-431.